Arctic Bioscience Logo

Arctic Bioscience

Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.

ABS | OL

Overview

Corporate Details

ISIN(s):
NO0010859580
LEI:
549300Z2HW6I989Q2C78
Country:
Norway
Address:
Industrivegen 42, 6155 ØRSTA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Arctic Bioscience is a biotechnology company that develops, manufactures, and commercializes pharmaceutical and nutraceutical ingredients derived from marine membrane lipids. Leveraging over 30 years of experience, the company utilizes proprietary technology to extract bioactive compounds, such as high-DHA Omega-3 phospholipids, from sustainably sourced Norwegian herring roe. Its business is structured into two main segments: a nutraceutical division, which markets products under the Romega® brand, and a pharmaceutical division focused on developing novel therapies for autoimmune disorders. The company's approach is founded on extensive scientific research and a commitment to sustainable practices.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Arctic Bioscience and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-28 08:00
Investor Presentation
Arctic Bioscience - Stable development with upside potential - Attachment: ABS_…
English 3.7 MB
2025-08-28 08:00
Investor Presentation
Arctic Bioscience - Stabil utvikling med oppsidepotensial - Attachment: ABS_Pre…
English 3.7 MB
2025-08-28 08:00
Interim Report
Arctic Bioscience - Stable development with upside potential - Attachment: ABS_…
English 457.5 KB
2025-08-28 08:00
Interim Report
Arctic Bioscience - Stabil utvikling med oppsidepotensial - Attachment: ABS_Hal…
English 457.5 KB
2025-08-28 08:00
Earnings Release
Arctic Bioscience - Stable development with upside potential
English 7.6 KB
2025-08-28 08:00
Earnings Release
Arctic Bioscience - Stabil utvikling med oppsidepotensial
Norwegian 7.8 KB
2025-08-21 12:19
Report Publication Announcement
Arctic Bioscience - Invitation to presentation of half year 2025 results
English 2.3 KB
2025-08-21 12:19
Report Publication Announcement
Arctic Bioscience - Invitasjon til presentasjon av halvårsresultat for 2025
Norwegian 2.2 KB
2025-08-18 10:28
Regulatory News Service
Arctic Bioscience - Signifikant synsforbedring i klinisk grønn stær-studie
Norwegian 2.6 KB
2025-08-18 10:28
Regulatory News Service
Arctic Bioscience - Achieves significant vision improvement in Clinical Glaucom…
English 2.6 KB
2025-08-12 13:46
Regulatory News Service
Arctic Bioscience lanserer nytt hudpleieprodukt - Romega Skin Refine
Norwegian 3.3 KB
2025-08-12 13:46
Regulatory News Service
Arctic Bioscience launches new skin care product - Romega Skin Refine
English 3.3 KB
2025-07-01 17:00
Investor Presentation
Arctic Bioscience - 12-month data confirm potential for HRO350 in mild-to-moder…
English 3.9 MB
2025-07-01 17:00
Investor Presentation
Arctic Bioscience - 12-måneders data bekrefter potensialet for HRO350 i mild ti…
English 3.9 MB
2025-07-01 17:00
Regulatory News Service
Arctic Bioscience - 12-month data confirm potential for HRO350 in mild-to-moder…
English 3.9 KB

Automate Your Workflow. Get a real-time feed of all Arctic Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Arctic Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Develops therapies for rare genetic diseases, CNS disorders, and regenerative medicine.
Japan 4552
Kadimastem Ltd. Logo
Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.
Israel KDST
kainos loboratories,inc Logo
Develops, manufactures, and sells innovative clinical diagnostic reagents for the healthcare industry.
Japan 4556
KAKEN PHARMACEUTIAL CO., LTD. Logo
R&D pharma firm creating drugs & devices for orthopedics, dermatology, and surgery globally.
Japan 4521
Kamada Ltd. Logo
Develops specialty plasma-derived therapeutics for rare and serious conditions.
Israel KMDA
KANABO GROUP PLC Logo
Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.
United Kingdom KNB
Kancera Logo
Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.
Sweden KAN
Karo Pharma AB Logo
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
Sweden KARO
Kidswell Bio Corporation Logo
Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.
Japan 4584
Kinarus Therapeutics Holding AG Logo
A specialty pharma firm developing and selling medicines for rare and specialty diseases.
Switzerland KNRS

Talk to a Data Expert

Have a question? We'll get back to you promptly.